Dovato 50-300 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM3BN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,280
Award facts
- Contract value 100% obligated
- $13,279.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,279.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Dovato 50-300 mg tablets (30-count units). The contract, which carries an ultimate completion date of January 27, 2026, was awarded on a fully competitive basis with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that supplies critical medications and medical commodities to federal agencies, particularly the Department of Defense and military treatment facilities. The Dovato supply under this delivery order supports the broader antimicrobial and antiviral pharmaceutical needs of the military healthcare system. AmerisourceBergen's extensive portfolio of federal contracts reflects its established capability to compete successfully for medical procurement requirements across multiple therapeutic domains, including specialty medications, generic drugs, vaccines, and medical devices, consistently delivering through firm fixed-price arrangements with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FM3BN?
SPE2DR26FM3BN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FM3BN worth?
The government has obligated $13,280 on SPE2DR26FM3BN.
Is contract SPE2DR26FM3BN an order under another contract?
Yes. SPE2DR26FM3BN is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3BN competed?
The extent of competition for SPE2DR26FM3BN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award